FIELD: medicine.
SUBSTANCE: present group of inventions relates to medicine and discloses a pharmaceutical composition (variants) in the form of a topical solution, which contains aminocaproic acid and a copolymer of 2-methyl-5-vinylpyridine with N-vinylpyrrolidone, components of phosphate buffered saline, preservative and purified water, as well as a method for preventing influenza and acute respiratory viral infection with these compositions.
EFFECT: group of inventions can be used in medical institutions for the prevention of influenza and ARVI.
12 cl, 1 dwg, 4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF AMINOCAPROIC ACID-BASED SPRAY AND COPOLYMER OF 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE | 2017 |
|
RU2669811C1 |
| ANTIVIRAL AND IMMUNOMODULATING COMBINATION OF AMINOCAPROIC ACID AND COPOLYMER OF 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE | 2017 |
|
RU2669810C1 |
| METHOD FOR QUANTITATIVE DETERMINATION OF AMINOCAPROIC ACID IN ITS SIMULTANEOUS PRESENCE WITH A COPOLYMER OF 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE BY THE METHOD OF HPLC | 2018 |
|
RU2700167C1 |
| INFLUENZA VACCINE AND METHOD FOR PREPARING IT | 2010 |
|
RU2446824C2 |
| OPHTHALMIC PREPARATION PRESENTED IN FORM OF EYE DROPS AND CONTAINING BRANCHED POLYHEXAMETHYLENE GUANIDINES AND POLY(N-VINYLPYRROLIDONE) | 2012 |
|
RU2509562C1 |
| N-VINYLPYRROLIDONE BASED COPOLYMERS | 2010 |
|
RU2415876C1 |
| COPOLYMER CONTAINING N-VINYL PYRROLIDONE, 2-METHYL-5-VINYL PYRIDINE AND 4-VINYL PYRIDINE LINKS | 2011 |
|
RU2459838C1 |
| COPOLYMERS OF 4-VINYLPYRIDINE OR 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE WITH TERMINAL CYANOVALERIC ACID RESIDUE AND USE THEREOF TO TREAT PNEUMOCONIOSIS | 2014 |
|
RU2550820C1 |
| INTERPOLYMER POLYELECTROLYTE COMPLEX AND A PROLONGED IMMUNOSTIMULATING AGENT ON ITS BASIS, FOR MEDICAL AND VETERINARY USE | 2017 |
|
RU2683947C1 |
| N-VINYLPYRROLIDONE-BASED COPOLYMERS IN FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS OF ACIDS | 2013 |
|
RU2533113C1 |
